US Patent 8841337 Compounds useful as inhibitors of ATR kinase
Patent 8841337 was granted and assigned to Vertex Pharmaceuticals on September, 2014 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 9, 2012
Date of Patent
September 23, 2014
Patent Applicant
Patent Application Number
13672949
Patent Inventor Names
John R. Studley
0
Jean-Damien Charrier
0
Joanne Pinder
0
Pierre-Henri Storck
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8841337 Compounds useful as inhibitors of ATR kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.